Pulse Biosciences, Inc. (PLSE) stock
PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$45.83+0.99 (+2.21%)
Close on Nov 18, 2026Market cap $3.27BP/E –Yield –
Pulse Biosciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pulse Biosciences's revenue for the twelve months ending Jun 30, 2026 was $1.19M. For fiscal 2025 it was $350.00K. The highest annual figure on record is $1.42M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $350.00K | – |
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $700.00K | -50.6% |
| FY2021 | Dec 31, 2021 | $1.42M | – |
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $434.00K | – |
| Q1 FY2026 | Mar 31, 2026 | $401.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $264.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $86.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $265.00K | – |
| Q1 FY2022 | Mar 31, 2022 | $444.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $844.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $574.00K | – |
See a number that looks wrong?